Everest Group Earnings Call Transcripts
Fiscal Year 2025
-
Q4 saw net operating income of $549M, a 14.2% ROE, and strong investment income, despite lower premiums from the retail exit and targeted underwriting. Share repurchases remain a priority, with $800M bought back in 2025 and more planned for 2026.
-
Exited global retail insurance, sold $2B renewal rights, and set a $1.2B adverse development cover to address legacy reserves. Core reinsurance and specialty businesses performed well, with strong capital flexibility and plans for resumed share repurchases.
-
Net operating income reached $734 million with a 19.6% ROE, driven by strong underwriting and investments. Reinsurance delivered robust profits and improved ratios, while insurance saw continued portfolio reshaping and international growth. Share repurchases totaled $200 million for the quarter.
-
Operating income reached $276 million despite significant catastrophe and aviation losses, with strong property and specialty growth offsetting U.S. casualty declines. Share repurchases and disciplined underwriting remain priorities, with continued attractive returns expected in property CAT and specialty lines.
-
Management took decisive action to strengthen reserves by $1.7 billion, overhauled leadership, and is aggressively remediating the U.S. casualty portfolio, aiming for a mid-teens shareholder return. The focus is on profitable growth in international and short-tail lines, with remediation to complete by end of 2025.
Fiscal Year 2024
-
2024 saw major reserve strengthening and portfolio remediation, especially in U.S. casualty, with strong growth in property and specialty lines offsetting exits from underperforming business. Despite significant catastrophe losses, book value and shareholder returns improved, and the company remains focused on disciplined underwriting and capital management.
-
Strong operating and investment results drove a 19.4% annualized shareholder return and 18.7% ROE year to date. Portfolio shifts favor property and specialty lines, with firming pricing expected at January renewals. Insurance combined ratio guidance remains on track, with capital strength supporting growth.
-
Q2 2024 saw strong growth in premiums, net income, and investment returns, with a 20% ROE and robust performance in both reinsurance and insurance segments. The company is on track to achieve its insurance combined ratio target by late 2025, supported by international expansion and disciplined underwriting.